Mesa Laboratories, Inc.
MLAB · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $644,205 | $603,232 | $929,738 | $1,328,435 |
| - Cash | $27,321 | $28,214 | $32,910 | $49,346 |
| + Debt | $181,472 | $231,297 | $170,272 | $221,133 |
| Enterprise Value | $798,356 | $806,315 | $1,067,100 | $1,500,222 |
| Revenue | $240,978 | $216,187 | $219,080 | $184,335 |
| % Growth | 11.5% | -1.3% | 18.8% | – |
| Gross Profit | $150,870 | $133,250 | $133,693 | $109,090 |
| % Margin | 62.6% | 61.6% | 61% | 59.2% |
| EBITDA | $42,347 | -$238,377 | $37,515 | $32,527 |
| % Margin | 17.6% | -110.3% | 17.1% | 17.6% |
| Net Income | -$1,974 | -$254,246 | $930 | $1,871 |
| % Margin | -0.8% | -117.6% | 0.4% | 1% |
| EPS Diluted | -0.36 | -47.2 | 0.17 | 0.35 |
| % Growth | 99.2% | -27,864.7% | -51.4% | – |
| Operating Cash Flow | $46,808 | $44,133 | $27,983 | $39,223 |
| Capital Expenditures | -$4,499 | -$2,567 | -$4,544 | -$4,432 |
| Free Cash Flow | $42,309 | $41,566 | $23,439 | $34,791 |